Hepatic Artery Infusion Therapy for Colorectal Cancer Metastasis

1.0 AMA PRA Category 1 Credit(s)™

The presentation will equip the audience with knowledge to identify patients with metastatic colorectal cancer and identify treatment options. A distinguished faculty will lead the conference summarizing the latest advances in treatment including the use of Hepatic Artery Infusion.

Target Audience

Gastroenterologist, Medical Oncologist, Surgical Oncologists, Colorectal Surgeons, Primary Care Physicians, Nurses and other allied health professionals.

Learning Objectives

  • Evaluate patients with Metastatic Colorectal Cancer using history, symptoms, imaging, and pathology to design a management plan for their treatment.
  • Educate physicians regarding various treatment options.
  • Summarize the role of Hepatic Artery infusion therapy for treatment.

Program Agenda

5:00 to 5:05 pm: Welcome

5:05 to 5:20 pm: Hepatic Artery Infusion Pump Therapy for Unresectable Colorectal Cancer
Brett L. Ecker, MD,
surgical oncologist, RWJBarnabas Health and Rutgers Cancer Institute of New Jersey

5:20 to 5:35 pm: Hepatic Artery Infusion Pump Therapy for Adjuvant Therapy
Russell C. Langan, MD, FACS, FSSO,
Associate Chief Surgical Officer for System Integration and Quality and Director of Surgical Oncology, Northern Region, RWJBarnabas Health and Rutgers Cancer Institute of New Jersey; Chief of Surgical Oncology and Hepatopancreatobiliary Surgery, Surgical Director of the Comprehensive Liver Center, Cooperman Barnabas Medical Center

5:35 to 5:50 pm: Surgical Robotic Placement of Hepatic Artery Infusion Pump
Jason Maggi, MD, surgical oncologist, RWJBarnabas Health and Rutgers Cancer Institute of New Jersey

5:50 to 6:05 pm: Questions and Answers/Open Discussion

Registration: Please register on Zoom for this virtual event.


AMA Credit Designation Statement: Cooperman Barnabas Medical Center designates this virtual educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation Statement: Cooperman Barnabas Medical Center is accredited by the Medical Society of New Jersey (MSNJ) to provide continuing medical education for physicians.

Disclosure Policy: It is the policy of Cooperman Barnabas Medical Center, Office of Continuing Medical Education to ensure balance, independence, transparency, objectivity and scientific rigor in all CME sponsored educational activities. All participating in the planning or implementation of a sponsored activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict(s) of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussion of unlabeled or unapproved drugs or devises. This information will be available as part of the activity material.

Faculty Disclosures: No relevant financial relationship(s) apply to this program.

Acknowledgement of Commercial Support: No commercial support was provided for this continuing educational activity.

Patient Safety Committee Work Product: Confidentiality Protection and Restrictions on Disclosure Pursuant to N.J.S.A. 26:2H-12.25b. & N.J.A.C. 8:43E-10.0